๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Optimal growth of human blood hematopoietic progenitor cells collected by apheresis for autografts

โœ Scribed by Atsushi Hirao; Yoichi Takaue; Yoshifumi Kawano; Junko Sato; Atsushi Makimoto; Masami Kawahito; Yasuhiro Okamoto; Shin-Ichi Saito; Takeshi Suzue; Takanori Abe; Yasuhiro Kuroda


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
581 KB
Volume
10
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

โœฆ Synopsis


For safe autografts with peripheral blood hematopoietic cells (PBSCT), better methods for determining the kinetics of stem cell populations and predicting engraftment speed after PBSCT need to be established. Current methods include culture in semi-solid medium and measurement of CD34 cell surface antigen. In this study with only partially purified blood cells obtained from children with cancer in remission, we compared the effects of phytohemagglutininstimulated lymphocyte-conditioned medium (PHA-LCM) and recombinant human cytokines on the growth of progenitor cells in a methylcellulose culture system. Interleukin-3 (IL-3) alone supported more progenitor growth than standard PHA-LCM by a factor of 1.54 for colony-forming unit granulocytelmacrophages (CFU-GM) and by a factor of 1.84 for burst-forming unit/erythroids (BFU-E). No significant change, in terms of the number of growing colonies, was observed by adding granulocyte/macrophage colony-stimulating factor (GM-CSF), granulocyte-CSF (G-CSF), or IL-1 to IL-3. However, the addition of G-CSF resulted in increased colony size. A further increase in CFU-GM growth was observed by the addition of IFN-y to the combination of cytokines. No significant effect was observed when stem cell factor (SCF) was added to the combination of cytokines containing IL-3, G-CSF, and IFN-y. This analysis suggests that the combination of IL-3, G-CSF, and IFN-y may provide sufficient stimulation for the growth of human blood cells. The effects of different oxygen tensions on progenitor growth in the presence of IL-3, G-CSF, and IFN-y were also evaluated. Both CFU-GM and BFU-E formation were increased when the culture was grown at 5% 0,, as compared with an ambient 20% 0, tension. A small number of infused cells were grown in culture incorporating either IL-3, G-CSF, and IFN--y at 5% 0, or PHA-LCM at 20% O,, and the number of infused cells was correlated to the speed of hematopoietic recovery after PBSCT. Although a significant negative correlation was observed between the number of infused CFU-GM per kilogram of the patient's body weight and the recovery of hematopoiesis under both culture conditions, a better correlation was found when the former method was applied ( P < ,001 vs. P < .OS).These findings suggest that a culture containing IL-3, G-CSF, and IFN-y at low 0, tension provides satisfactory conditions for the proliferation of blood progenitors, and that this mixture of recombinant cytokines may enable a standardized hematopoietic progenitor assay for PBSCT.


๐Ÿ“œ SIMILAR VOLUMES


Selection of appropriate venous access f
โœ Sheryl McDiarmid; Christopher Bredeson; Lothar B. Huebsch ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 63 KB ๐Ÿ‘ 2 views

Peripheral blood progenitor cells (PBPC) have been extensively used to restore hematopoiesis after myeloablative chemotherapy. While collection regimens designed for optimal mobilization of PBPC are becoming standardized, the ideal venous access option for collection remains unresolved. The purpose

Predictive value of the original content
โœ Tsuneo Itoh; Masayoshi Minegishi; Yoshinori Kudo; Naoko Saito; Hiroyuki Takahash ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB

We retrospectively investigated the feasibility of the apheresis procedure for red blood cell (RBC) reduction with a closed-bag system. We also sought to determine the optimal processing volume for the maximal recovery of hematopoietic progenitor cells (HPC). Twelve bone marrow (BM) harvests were pr

Non-cryopreserved peripheral blood proge
โœ Christos A. Papadimitriou; Meletios A. Dimopoulos; Vassilios Kouvelis; Evangelos ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 38 KB ๐Ÿ‘ 2 views

High-dose chemotherapy with autologous peripheral blood progenitor cell (PBPC) support has become a widely used treatment strategy. In order to simplify the procedure, a single very large-volume leukapheresis programme combined with short-term refrigerated storage of the PBPC was developed. Seventy-